Fermenta Biotech Ltd
Fermenta Biotech Ltd Share Price Today: Live Updates & Key Insights
Get insights on Fermenta Biotech Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Fermenta Biotech Ltd Share Price Chart
FERMENTABIOTEC at 28 Jan 2026 04:27 PM Pharmaceuticals
327.95 +10.50(+3.31%)
Lowest Today 313.20
Highest Today 328.40
Today's Open 320.00
Prev. Close 317.45
52 Week High 449.00
52 Week Low 219.00
Fermenta Biotech Ltd Fundamentals
Traded Volume: 5,062
Market Cap(Cr): 965
Avg Traded Price 319.90
1 Year return -12.09%
Upper Circuit 328.4
Lower Circuit 313.2
P/E TTM 0.00
P/B Ratio 2.553
Traded Value(Cr) 16.60
EPS TTM NaN
Book value/Share 124.330
Dividend Yield 1Y 0.00%
Fermenta Biotech Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Fermenta Biotech Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Fermenta Biotech Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y -12.09%
YTD 0.00%
Fermenta Biotech Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Fermenta Biotech Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Fermenta Biotech Ltd Technical Details
Fermenta Biotech Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 314
Support 2 311
Support 3 307
Pivot Point : 318
Resistance 1 321
Resistance 2 325
Resistance 3 328
Fermenta Biotech Ltd Corporate Actions
Fermenta Biotech Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Fermenta Biotech Ltd’s capital allocation strategies.
All
Ex-Date 06-Aug-2025 Type D Description 2.50/share@50.00% Record Date 06-Aug-2025 Ratio 50.00
Ex-Date 06-Aug-2024 Type D Description 1.25/share@25.00% Record Date 06-Aug-2024 Ratio 25.00
Ex-Date 22-Sep-2023 Type D Description 1.25/share@25.00% Record Date 22-Sep-2023 Ratio 25.00
Ex-Date 04-Aug-2022 Type D Description 1.25/share@25.00% Record Date 05-Aug-2022 Ratio 25.00
Ex-Date 25-Aug-2021 Type D Description 2.50/share@50.00% Record Date - Ratio 50.00
Ex-Date 13-Feb-2020 Type B Description share@2:1 Record Date 14-Feb-2020 Ratio 2:1
Ex-Date 22-Nov-2019 Type D Description 5.00/share@100.00% Record Date 25-Nov-2019 Ratio 100.00
Ex-Date 28-Jun-2019 Type D Description 1.25/share@25.00% Record Date - Ratio 25.00
Ex-Date 19-Sep-2018 Type D Description 1.25/share@25.00% Record Date - Ratio 25.00
Ex-Date 08-Aug-2018 Type B Description share@1:1 Record Date 09-Aug-2018 Ratio 1:1
Ex-Date 08-Aug-2018 Type S Description share@1:2.00 Record Date 09-Aug-2018 Ratio 1:2.00
Ex-Date 21-Sep-2017 Type D Description 2.50/share@25.00% Record Date - Ratio 25.00
Ex-Date 19-Sep-2016 Type D Description 2.50/share@25.00% Record Date - Ratio 25.00
Ex-Date 10-Sep-2014 Type D Description 2.50/share@25.00% Record Date - Ratio 25.00
Ex-Date 24-Feb-2014 Type D Description 7.50/share@75.00% Record Date 25-Feb-2014 Ratio 75.00
Ex-Date 13-Sep-2012 Type D Description 15.00/share@150.00% Record Date - Ratio 150.00
Ex-Date 05-Jul-2012 Type D Description 15.00/share@150.00% Record Date 06-Jul-2012 Ratio 150.00
Ex-Date 23-Feb-2012 Type D Description 15.00/share@150.00% Record Date 24-Feb-2012 Ratio 150.00
Ex-Date 15-Sep-2011 Type D Description 10.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 22-Feb-2011 Type D Description 15.00/share@150.00% Record Date 23-Feb-2011 Ratio 150.00
Ex-Date 15-Sep-2010 Type D Description 7.50/share@75.00% Record Date - Ratio 75.00
Ex-Date 03-Jun-2010 Type D Description 7.50/share@75.00% Record Date 04-Jun-2010 Ratio 75.00
Ex-Date 17-Sep-2009 Type D Description 7.50/share@75.00% Record Date - Ratio 75.00
Ex-Date 29-Jun-2009 Type D Description 7.50/share@75.00% Record Date 30-Jun-2009 Ratio 75.00
Ex-Date 18-Sep-2008 Type D Description 10.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 06-Sep-2007 Type D Description 5.00/share@50.00% Record Date - Ratio 50.00
Dividends
Announcement Date 06-Aug-2025 Ex Dividend Date 06-Aug-2025 Dividend(%) 50
Announcement Date 06-Aug-2024 Ex Dividend Date 06-Aug-2024 Dividend(%) 25
Announcement Date 22-Sep-2023 Ex Dividend Date 22-Sep-2023 Dividend(%) 25
Announcement Date 04-Aug-2022 Ex Dividend Date 04-Aug-2022 Dividend(%) 25
Announcement Date 25-Aug-2021 Ex Dividend Date 25-Aug-2021 Dividend(%) 50
Announcement Date 22-Nov-2019 Ex Dividend Date 22-Nov-2019 Dividend(%) 100
Announcement Date 28-Jun-2019 Ex Dividend Date 28-Jun-2019 Dividend(%) 25
Announcement Date 19-Sep-2018 Ex Dividend Date 19-Sep-2018 Dividend(%) 25
Announcement Date 21-Sep-2017 Ex Dividend Date 21-Sep-2017 Dividend(%) 25
Announcement Date 19-Sep-2016 Ex Dividend Date 19-Sep-2016 Dividend(%) 25
Announcement Date 10-Sep-2014 Ex Dividend Date 10-Sep-2014 Dividend(%) 25
Announcement Date 24-Feb-2014 Ex Dividend Date 24-Feb-2014 Dividend(%) 75
Announcement Date 13-Sep-2012 Ex Dividend Date 13-Sep-2012 Dividend(%) 150
Announcement Date 05-Jul-2012 Ex Dividend Date 05-Jul-2012 Dividend(%) 150
Announcement Date 23-Feb-2012 Ex Dividend Date 23-Feb-2012 Dividend(%) 150
Announcement Date 15-Sep-2011 Ex Dividend Date 15-Sep-2011 Dividend(%) 100
Announcement Date 22-Feb-2011 Ex Dividend Date 22-Feb-2011 Dividend(%) 150
Announcement Date 15-Sep-2010 Ex Dividend Date 15-Sep-2010 Dividend(%) 75
Announcement Date 03-Jun-2010 Ex Dividend Date 03-Jun-2010 Dividend(%) 75
Announcement Date 17-Sep-2009 Ex Dividend Date 17-Sep-2009 Dividend(%) 75
Announcement Date 29-Jun-2009 Ex Dividend Date 29-Jun-2009 Dividend(%) 75
Announcement Date 18-Sep-2008 Ex Dividend Date 18-Sep-2008 Dividend(%) 100
Announcement Date 06-Sep-2007 Ex Dividend Date 06-Sep-2007 Dividend(%) 50
Bonus
Record Date 14-Feb-2020 Ex-Bonus Date 13-Feb-2020 Ratio 2:1
Record Date 09-Aug-2018 Ex-Bonus Date 08-Aug-2018 Ratio 1:1
Splits
Record Date 09-Aug-2018 Split Date 08-Aug-2018 Face Value (Before/After) 10.00/5.00
Others
Rights No Rights has been declared by FERMENTABIOTEC
Fermenta Biotech Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Fermenta Biotech Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Fermenta Biotech Ltd's relative performance and valuation against major competitors.
Stock Name Bajaj Healthcare Ltd ₹343.30 (+3.25%) M. Cap (Cr) 10.84 1 Yr Return (%) -35.23% P/E (TTM) 21.77 PB Ratio 2.23
Stock Name Venus Remedies Ltd ₹745.45 (-0.36%) M. Cap (Cr) 9.96 1 Yr Return (%) +160.56% P/E (TTM) 14.17 PB Ratio 1.68
Stock Name NGL Fine Chem Ltd ₹1710.50 (+9.21%) M. Cap (Cr) 10.57 1 Yr Return (%) +0.17% P/E (TTM) 51.08 PB Ratio 3.52
Stock Name Fermenta Biotech Ltd ₹327.95 (+3.31%) M. Cap (Cr) 9.65 1 Yr Return (%) -12.09% P/E (TTM) 8.62 PB Ratio 2.47
Stock Name Lincoln Pharmaceuticals Ltd ₹449.05 (-0.14%) M. Cap (Cr) 8.99 1 Yr Return (%) -33.98% P/E (TTM) 11.24 PB Ratio 1.26
Stock Name Ind-Swift Laboratories Ltd ₹108.70 (+1.57%) M. Cap (Cr) 8.87 1 Yr Return (%) +2.20% P/E (TTM) 3.71 PB Ratio 0.68
Stock Name Sakar Healthcare Ltd ₹379.75 (+0.58%) M. Cap (Cr) 8.45 1 Yr Return (%) +30.63% P/E (TTM) 43.32 PB Ratio 2.79
Fermenta Biotech Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Fermenta Biotech Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 33.83 Mar 2024 105.02 Mar 2023 124.46 Mar 2022 50.41 Mar 2021 62.96
PARTICULARS Investing Activities Mar 2025 0.41 Mar 2024 -15.15 Mar 2023 -64.44 Mar 2022 -32.46 Mar 2021 -43.61
PARTICULARS Financing Activities Mar 2025 -50.91 Mar 2024 -90.86 Mar 2023 -40.80 Mar 2022 -21.76 Mar 2021 -1.32
PARTICULARS Net Cash Flow Mar 2025 -16.67 Mar 2024 -0.98 Mar 2023 19.22 Mar 2022 -3.81 Mar 2021 18.03
Fermenta Biotech Ltd Shareholding Pattern
This shows the ownership breakdown of Fermenta Biotech Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Fermenta Biotech Ltd
Fermenta Biotech Limited was formerly incorporated as 'Duphar-Interfran Limited' in May, 1951. The Company name was changed to 'DIL Limited' in September, 2003 and later on, was changed to 'Fermenta Biotech Limited' on October 17, 2019. The Company is presently engaged in pharmaceuticals, manufacturing and marketing Active Pharmaceutical Ingredients, biotechnology, environmental solutions and renting of properties.Initially, Company manufactured and sold toothpaste, anti-septic lotion and pharmaceutical specialities. It entered into collaborations with Philips-Duphar, Amsterdam (Solvay Duphar), and the Crookes Laboratories, London. These collaborators participated in the equity capital of the Company to the extent of 25% each.In 1964, Company entered into a collaboration with Solvay Duphar to manufacture vitamin D3. In 1976, it entered into another collaboration with Solvay Duphar to manufacture isoxypurine hydrochloride -- a vasodilator. In 1976, in compliance with the FERA, the foreign collaborators reduced thier stake to 38.86%.Company came out with a rights issue in May '95 to augment long-term resources and working capital requirements. The company also sold its popular analgesic brand Crocin to Smithkline Beecham Pharmaceuticals. It also sold another OTC brand, Lacto-Calamine lotion to Nicholas Piramal to concentrate on the core business of ethical drugs.As per the Scheme of Arrangement, the Pharma Division of the Company was transferred to Duphar Pharma India. The Company has made investments in unutilised premises at Thane to create a commercial complex with modern facilities so that substantial portion of it can be let out to earn income. The successful entry of Annual Contract with Solvay Pharmaceuticals B V of Netherlands will definitely establish as a reliable contract research organization for Duphar Interfran Ltd. As mutual consent with Solvay Pharmaceuticals,Netherlands,the company has been permitted to continue with the name DUPHAR for a limited time. It has also been decided to change the name to DIL Limited from Duphar-Interfran Ltd.With the prior approval from Board the company has acquired 990,000 equity shares of Rs.10 each in Fermenta Biotech Ltd there by increase its holding to 83.71% comprising 16,57,500 equity shares. Subsequent to this FBL will henceforth be a subsidiary of Duphar Interfran Ltd.In 2003, the Company expanded manufacturing capacity with Vitamin D and other products such as Phenyramidol at Kullu. During the year 2009-10, the Company carried out the Drug Discovery and Development Services through its subsidiaries, Evotec (India) Private Limited and its subsidiary Evotec-RSIL Limited up to August 31, 2009. Through the divestment of 70% equity shares by the Company in Evotec (India) Private Limited, Evotec (India) Private Limited and its subsidiary Evotec-RSIL Limited ceases to be subsidiaries of the Company with effect from September 01, 2009. New projects were undertaken with Bayer CropSciences, Novartis, Boehringer Ingelheim and Chugai. The Company commissioned a new manufacturing facility at Dahej SEZ, Gujarat during 2010-11. The Company executed a definitive agreements with a private equity investor in Mauritius, Evolvence India Life Sciences Fund LLC (EILSF) on December 10, 2010 for sale of 1,915,036 equity shares held by Company in FBL to EILSF and issue of an equal number of fresh equity shares by FBL to EILSF, for a total consideration of Rs. 40 crores, which was completed in Jan'11. It launched new and improved Penicillin G Acylase catalyst - Fermase PA 850 in 2012.Agastya Films LLP and Zela Wellness Private Limited ceased to be joint venture entity and associate company w.e.f. January 01, 2019 and Novemeber 29, 2018 respectively. The Company in FY 2019-20, launched a new product, fish oil derived cholesterol, for the aquaculture market, it launched a new version of Vitamin D 500 feed grade powder in 2020. During the year 2019-20, the Scheme of Amalgamation between the Parent i.e. DIL Limited (DIL) and its subsidiary, Fermenta Biotech Limited (FBL) and their respective shareholders became effective from September 26, 2019, with the appointed date as April 01, 2018. On September 5, 2019, the Company's subsidiary viz. Fermenta Biotech GmbH was incorporated in Germany. The Company incorporated a wholly-owned subsidiary in the United States of America viz. Fermenta Biotech USA LLC on May 27, 2020. In December 2020, Fermenta Biotech USA LLC, a wholly owned subsidiary of the Company, acquired 52% membership interest in AGD Nutrition, LLC (now known as Fermenta USA, LLC). In FY 2021-22, the Company launched Vitamin AD2 for oil fortification and developed patented technology for enzymatic synthesis of Molnupiravir.The Company commissioned a a manufacturing facility for Fortified Rice Kernel (FRK) in Pennepalli, Andhra Pradesh in 2022. The Scheme of Amalgamation amongst DVK Investments Private Limited and Aegean Properties Limited and the Company and their respective Shareholders was made effective on May 24, 2023. Post Effective Date, the Company issued and allotted 150,75,318 equity shares of face value of Rs. 5/- each, fully paid-up, to the members of DVK Investments Private Limited on June 02, 2023. As per the terms of NCLT Order dated May 8, 2023 regarding Composite Scheme of Amalgamation and Arrangement, the Company's Holding company, DVK Investments Private Limited and the Company's subsidiary, Aegean Properties Limited ceased to exist w.e.f. May 24, 2023.The Company commissioned its Customized Premixing Plant in Kullu, Himachal Pradesh in 2024. The Company transferred plant-source Vitamin D3 technology from R&D to manufacturing EU GMP and US FDA certifications for Dahej facility in FY 2024-25.
Executive Director
Satish Varma
Registered office A-1501 DIL Complex Majiwada, Ghodbunder Road Thane One, Thane (West), Maharashtra, 400610
FAX :91-22-66230800/888
Background
Incorporation Year 1951
Face Value ₹5.00
Market Lot 1
FAQs on Fermenta Biotech Ltd
How to buy Fermenta Biotech Ltd shares on NSE?
To buy Fermenta Biotech Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Fermenta Biotech Ltd share price today?
The Fermenta Biotech Ltd share price on NSE is ₹327.95 today.
What is the market cap of Fermenta Biotech Ltd on NSE?
The company has a market capitalization of ₹965.19.
What is the PE & PB ratio of Fermenta Biotech Ltd?
PE is N/A and PB is 2.553.
What is the 52 Week High and Low of Fermenta Biotech Ltd shares?
Fermenta Biotech Ltd stock price high: ₹449 Fermenta Biotech Ltd stock price low: ₹219.